Liečba rakoviny (Slovak Wikipedia)

Analysis of information sources in references of the Wikipedia article "Liečba rakoviny" in Slovak language version.

refsWebsite

Global rank Slovak rank

17doi.org

2^nd place

7^th place

16nih.gov

4^th place

21^st place

5web.archive.org

1^st place

8^th place

2nature.com

234^th place

71^st place

2pubstemcell.com

low place

2fda.gov

447^th place

1,701^st place

2elsevier.com

610^th place

631^st place

1economist.com

254^th place

675^th place

1books.google.com

3^rd place

37^th place

1cancer.gov

1,684^th place

2,262^nd place

1cdc.gov

218^th place

173^rd place

1livescience.com

1,190^th place

216^th place

1worldcat.org

5^th place

1^st place

1cancernetwork.com

low place

8,048^th place

1oxfordjournals.org

1,389^th place

1,767^th place

1who.int

195^th place

188^th place

1bmjjournals.com

low place

1solen.sk

low place

222^nd place

1investorroom.com

low place

1translational-medicine.com

low place

1alphamedpress.org

low place

1ascopubs.org

low place

1wiley.com

222^nd place

174^th place

1curado.de

low place

alphamedpress.org

theoncologist.alphamedpress.org

Complementary and alternative therapies for cancer. Oncologist, 2004, s. 80 – 9. Dostupné online. DOI: 10.1634/theoncologist.9-1-80. PMID 14755017. Archivované 2009-08-27 na Wayback Machine

ascopubs.org

jco.ascopubs.org

Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol, 1. júl 2000, s. 2505 – 14. Dostupné online. PMID 10893280.

bmjjournals.com

bmj.bmjjournals.com

Are experimental treatments for cancer in children superior to established treatments? Observational study of randomised controlled trials by the Children's Oncology Group. BMJ, 2005, s. 1295. Dostupné online. DOI: 10.1136/bmj.38628.561123.7C. PMID 16299015.

books.google.com

Enger, Eldon. Concepts in Biology' 2007 Ed.2007 Edition. [s.l.] : McGraw-Hill. Dostupné online. ISBN 978-0-07-126042-8. S. 173.

cancer.gov

What Is Cancer? [online]. National Cancer Institute, [cit. 2009-08-17]. Dostupné online.

cancernetwork.com

Cancer Management: A Multidisciplinary Approach. 11. vyd. [s.l.] : [s.n.], 2008. Dostupné online. Principles of Oncologic Pharmacotherapy. Archivované 2013-10-04 na Wayback Machine

cdc.gov

atsdr.cdc.gov

Cancer Fact Sheet [online]. Agency for Toxic Substances & Disease Registry, 2002-08-30, [cit. 2009-08-17]. Dostupné online. Archivované 2009-08-13 z originálu.

curado.de

Krebstherapie in der Schwangerschaft extrem schwierig [online]. Curado, 2009-02-20, [cit. 2009-06-06]. Dostupné online. (German) Archivované 2016-03-06 na Wayback Machine

doi.org

dx.doi.org

HAYDEN, Erika C.. Cutting off cancer's supply lines. Nature, 2009-04-08, s. 686 – 687. Dostupné online. DOI: 10.1038/458686b. PMID 19360048.
Surgical treatment of localised renal cancer. European Urology Supplements, 2012, s. 60 – 65. ISSN 1569-9056. DOI: 10.1016/j.eursup.2012.04.002.
Neoadjuvant chemotherapy in lung cancer. Therapy, 2011, s. 23 – 31. DOI: 10.2217/thy.10.82.
DOLMANS, DE; Fukumura D; Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer, May 2003, s. 380 – 7. Dostupné online. DOI: 10.1038/nrc1071. PMID 12724736.
Increasing the density of nanomedicines improves their ultrasound-mediated delivery to tumours. Journal of Controlled Release, 2015, s. 10 – 18. DOI: 10.1016/j.jconrel.2015.05.265.
Gene therapy for antiangiogenesis. J. Natl. Cancer Inst., July 2001, s. 965 – 7. Dostupné online. DOI: 10.1093/jnci/93.13.965. PMID 11438554.
DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes. J. Clin. Oncol., 2006, s. 3799 – 808. DOI: 10.1200/JCO.2005.05.4171. PMID 16896009.
Synthetic lethality: exploiting the addiction of cancer to DNA repair. Blood, 2011, s. 6074 – 82. DOI: 10.1182/blood-2011-01-313734. PMID 21441464.
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial. Lancet Oncol., 2014, s. 852 – 61. DOI: 10.1016/S1470-2045(14)70228-1. PMID 24882434.
Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies. Nat Commun, 2016, s. 12425. DOI: 10.1038/ncomms12425. PMID 27498558.
Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. Proc. Natl. Acad. Sci. U.S.A., 2006, s. 8822 – 7. DOI: 10.1073/pnas.0600645103. PMID 16723399.
Are experimental treatments for cancer in children superior to established treatments? Observational study of randomised controlled trials by the Children's Oncology Group. BMJ, 2005, s. 1295. Dostupné online. DOI: 10.1136/bmj.38628.561123.7C. PMID 16299015.
MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol., July 2008, s. 13 – 21. Dostupné online. DOI: 10.1016/j.ygyno.2008.04.033. PMID 18589210.
Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer, January 2009, s. 42 – 6. Dostupné online. DOI: 10.3816/CLC.2009.n.006. PMID 19289371.
Exosomes as a tumor immune escape mechanism: possible therapeutic implications. J Transl Med, 2008, s. 37. Dostupné online. DOI: 10.1186/1479-5876-6-37. PMID 18644158.
Complementary and alternative therapies for cancer. Oncologist, 2004, s. 80 – 9. Dostupné online. DOI: 10.1634/theoncologist.9-1-80. PMID 14755017. Archivované 2009-08-27 na Wayback Machine
Vickers A. Alternative cancer cures: 'unproven' or 'disproven'?. CA Cancer J Clin, 2004, s. 110 – 8. Dostupné online. DOI: 10.3322/canjclin.54.2.110. PMID 15061600.

economist.com

Cancer drugs are getting better and dearer [online]. The Economist, [cit. 2017-07-09]. Dostupné online.

elsevier.com

linkinghub.elsevier.com

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol., July 2008, s. 13 – 21. Dostupné online. DOI: 10.1016/j.ygyno.2008.04.033. PMID 18589210.
Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer, January 2009, s. 42 – 6. Dostupné online. DOI: 10.3816/CLC.2009.n.006. PMID 19289371.

fda.gov

YAO, Stephanie. FDA approves Lynparza to treat advanced ovarian cancer: First LDT companion diagnostic test also approved to identify appropriate patients [online]. U.S. Food and Drug Administration, 19 December 2014. Dostupné online.
COMMISSIONER, Office of the. Press Announcements - FDA grants accelerated approval to new treatment for advanced ovarian cancer [online]. www.fda.gov, [cit. 2019-02-15]. Dostupné online. (po anglicky)

investorroom.com

aethlonmedical.investorroom.com

Aethlon Medical Announces Data Against Metastatic Melanoma - Sep 9, 2010 [online]. Aethlonmedical.investorroom.com, 2010-09-09, [cit. 2013-06-21]. Dostupné online. Archivované 2011-08-11 z originálu.

livescience.com

WANJEK, Christopher. Exciting New Cancer Treatments Emerge Amid Persistent Myths [online]. 2006-09-16, [cit. 2009-08-17]. Dostupné online.

nature.com

HAYDEN, Erika C.. Cutting off cancer's supply lines. Nature, 2009-04-08, s. 686 – 687. Dostupné online. DOI: 10.1038/458686b. PMID 19360048.
DOLMANS, DE; Fukumura D; Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer, May 2003, s. 380 – 7. Dostupné online. DOI: 10.1038/nrc1071. PMID 12724736.

nih.gov

ncbi.nlm.nih.gov

HAYDEN, Erika C.. Cutting off cancer's supply lines. Nature, 2009-04-08, s. 686 – 687. Dostupné online. DOI: 10.1038/458686b. PMID 19360048.
DOLMANS, DE; Fukumura D; Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer, May 2003, s. 380 – 7. Dostupné online. DOI: 10.1038/nrc1071. PMID 12724736.
Gene therapy for antiangiogenesis. J. Natl. Cancer Inst., July 2001, s. 965 – 7. Dostupné online. DOI: 10.1093/jnci/93.13.965. PMID 11438554.
DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes. J. Clin. Oncol., 2006, s. 3799 – 808. DOI: 10.1200/JCO.2005.05.4171. PMID 16896009.
Synthetic lethality: exploiting the addiction of cancer to DNA repair. Blood, 2011, s. 6074 – 82. DOI: 10.1182/blood-2011-01-313734. PMID 21441464.
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial. Lancet Oncol., 2014, s. 852 – 61. DOI: 10.1016/S1470-2045(14)70228-1. PMID 24882434.
Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies. Nat Commun, 2016, s. 12425. DOI: 10.1038/ncomms12425. PMID 27498558.
Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. Proc. Natl. Acad. Sci. U.S.A., 2006, s. 8822 – 7. DOI: 10.1073/pnas.0600645103. PMID 16723399.
Are experimental treatments for cancer in children superior to established treatments? Observational study of randomised controlled trials by the Children's Oncology Group. BMJ, 2005, s. 1295. Dostupné online. DOI: 10.1136/bmj.38628.561123.7C. PMID 16299015.
MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol., July 2008, s. 13 – 21. Dostupné online. DOI: 10.1016/j.ygyno.2008.04.033. PMID 18589210.
Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer, January 2009, s. 42 – 6. Dostupné online. DOI: 10.3816/CLC.2009.n.006. PMID 19289371.
Exosomes as a tumor immune escape mechanism: possible therapeutic implications. J Transl Med, 2008, s. 37. Dostupné online. DOI: 10.1186/1479-5876-6-37. PMID 18644158.
Complementary and alternative therapies for cancer. Oncologist, 2004, s. 80 – 9. Dostupné online. DOI: 10.1634/theoncologist.9-1-80. PMID 14755017. Archivované 2009-08-27 na Wayback Machine
Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol, 1. júl 2000, s. 2505 – 14. Dostupné online. PMID 10893280.
Vickers A. Alternative cancer cures: 'unproven' or 'disproven'?. CA Cancer J Clin, 2004, s. 110 – 8. Dostupné online. DOI: 10.3322/canjclin.54.2.110. PMID 15061600.

nccih.nih.gov

What Is CAM? National Center for Complementary and Integrative Health. retrieved 3 February 2008.

oxfordjournals.org

jnci.oxfordjournals.org

Gene therapy for antiangiogenesis. J. Natl. Cancer Inst., July 2001, s. 965 – 7. Dostupné online. DOI: 10.1093/jnci/93.13.965. PMID 11438554.

pubstemcell.com

DAMODAR, S; Terunuma H; Abraham S. Autologous Immune Enhancement Therapy (AIET) for a Case of Acute Myeloid Leukemia (AML) – Our Experience. Pasrm 2006 – 001, October 2006. Dostupné online.
SIVARAMAN, G; Pandian A; Abraham S. Autologous Immune Enhancement therapy for Advanced Carcinoma of Pancreas-A Case Report. Pasrm 2008 – 004, October 2008. Dostupné online.

solen.sk

ZDURJENČÍKOVÁ A SPOL., Martina. Exozómy – nová téma v diagnostike nádorových ochorení [online]. Solen, [cit. 2019-02-15]. Dostupné online.

translational-medicine.com

Exosomes as a tumor immune escape mechanism: possible therapeutic implications. J Transl Med, 2008, s. 37. Dostupné online. DOI: 10.1186/1479-5876-6-37. PMID 18644158.

web.archive.org

Cancer Fact Sheet [online]. Agency for Toxic Substances & Disease Registry, 2002-08-30, [cit. 2009-08-17]. Dostupné online. Archivované 2009-08-13 z originálu.
Cancer Management: A Multidisciplinary Approach. 11. vyd. [s.l.] : [s.n.], 2008. Dostupné online. Principles of Oncologic Pharmacotherapy. Archivované 2013-10-04 na Wayback Machine
Aethlon Medical Announces Data Against Metastatic Melanoma - Sep 9, 2010 [online]. Aethlonmedical.investorroom.com, 2010-09-09, [cit. 2013-06-21]. Dostupné online. Archivované 2011-08-11 z originálu.
Complementary and alternative therapies for cancer. Oncologist, 2004, s. 80 – 9. Dostupné online. DOI: 10.1634/theoncologist.9-1-80. PMID 14755017. Archivované 2009-08-27 na Wayback Machine
Krebstherapie in der Schwangerschaft extrem schwierig [online]. Curado, 2009-02-20, [cit. 2009-06-06]. Dostupné online. (German) Archivované 2016-03-06 na Wayback Machine

who.int

WHO's pain ladder [online]. World Health Organization. Dostupné online.

wiley.com

onlinelibrary.wiley.com

Vickers A. Alternative cancer cures: 'unproven' or 'disproven'?. CA Cancer J Clin, 2004, s. 110 – 8. Dostupné online. DOI: 10.3322/canjclin.54.2.110. PMID 15061600.

worldcat.org

Surgical treatment of localised renal cancer. European Urology Supplements, 2012, s. 60 – 65. ISSN 1569-9056. DOI: 10.1016/j.eursup.2012.04.002.